Literature DB >> 29070546

Impact of chronic and acute inflammation on extra- and intracellular iron homeostasis.

A Catharine Ross1.   

Abstract

Inflammation has a major impact on iron homeostasis. This review focuses on acute and chronic inflammation as it affects iron trafficking and, as a result, the availability of this essential micronutrient to the host. In situations of microbial infection, not only the host is affected but also the offending microorganisms, which, in general, not only require iron for their own growth but have evolved mechanisms to obtain it from the infected host. Key players in mammalian iron trafficking include several types of cells important to iron acquisition, homeostasis, and hematopoiesis (enterocytes, hepatocytes, macrophages, hematopoietic cells, and in the case of pregnancy, placental syncytiotrophoblast cells) and several forms of chaperone proteins, including, for nonheme iron, the transport protein transferrin and the intracellular iron-storage protein ferritin, and for heme iron, the chaperone proteins haptoglobin and hemopexin. Additional key players are the cell membrane-associated iron transporters, particularly ferroportin (FPN), the only protein known to modulate iron export from cells, and finally, the iron-regulatory hormone hepcidin, which, in addition to having antibacterial activity, regulates the functions of FPN. Interestingly, the impact of infection on iron homeostasis differs among pathogens whose mode of infection is mainly intracellular or extracellular. Understanding how inflammation affects each of these processes may be crucial for understanding how inflammation affects iron status, indicators of iron sufficiency, and iron supplementation during inflammation and how it may potentially result in a beneficial or detrimental impact on the host.
© 2017 American Society for Nutrition.

Entities:  

Keywords:  C-reactive protein; acute phase response; ferroportin; hepatocyte; hepcidin; infancy; intra- and extracellular pathogens; macrophage; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 29070546      PMCID: PMC5701715          DOI: 10.3945/ajcn.117.155838

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  47 in total

Review 1.  Cellular iron: ferroportin is the only way out.

Authors:  Tomas Ganz
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

Review 2.  Regulatory T cells and immune tolerance in the intestine.

Authors:  Oliver J Harrison; Fiona M Powrie
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

Review 3.  Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism.

Authors:  Henry K Bayele; Surjit Kaila S Srai
Journal:  Haematologica       Date:  2009-09       Impact factor: 9.941

Review 4.  Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms.

Authors:  C Trautwein; K Böker; M P Manns
Journal:  Gut       Date:  1994-09       Impact factor: 23.059

Review 5.  Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE).

Authors:  Daniel J Raiten; Fayrouz A Sakr Ashour; A Catharine Ross; Simin N Meydani; Harry D Dawson; Charles B Stephensen; Bernard J Brabin; Parminder S Suchdev; Ben van Ommen
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

6.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis.

Authors:  Adriana Donovan; Christine A Lima; Jack L Pinkus; Geraldine S Pinkus; Leonard I Zon; Sylvie Robine; Nancy C Andrews
Journal:  Cell Metab       Date:  2005-03       Impact factor: 27.287

Review 7.  Iron, anaemia, and inflammatory bowel diseases.

Authors:  C Gasche; M C E Lomer; I Cavill; G Weiss
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Hepcidin levels are low during pregnancy and increase around delivery in women without iron deficiency - a prospective cohort study.

Authors:  Katrine K Hedengran; Dick Nelson; Malene R Andersen; Steen Stender; Pal B Szecsi
Journal:  J Matern Fetal Neonatal Med       Date:  2015-07-27

Review 9.  Heme oxygenase-1 in placental development and pathology.

Authors:  K Levytska; J Kingdom; D Baczyk; S Drewlo
Journal:  Placenta       Date:  2013-02-09       Impact factor: 3.481

Review 10.  Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.

Authors:  Ann Smith; Russell J McCulloh
Journal:  Front Physiol       Date:  2015-06-30       Impact factor: 4.566

View more
  15 in total

1.  A Food-Derived Dietary Supplement Containing a Low Dose of Iron Improved Markers of Iron Status Among Nonanemic Iron-Deficient Women.

Authors:  Christopher R D'Adamo; James S Novick; Termeh M Feinberg; Valerie J Dawson; Larry E Miller
Journal:  J Am Coll Nutr       Date:  2018-03-13       Impact factor: 3.169

Review 2.  Iron-Deficiency in Atopic Diseases: Innate Immune Priming by Allergens and Siderophores.

Authors:  Franziska Roth-Walter
Journal:  Front Allergy       Date:  2022-05-10

3.  Iron and zinc homeostases in female rats with physically active and sedentary lifestyles.

Authors:  Andrew J Ghio; Joleen M Soukup; Caroline Ghio; Christopher J Gordon; Judy E Richards; Mette C Schladweiler; Samantha J Snow; Urmila P Kodavanti
Journal:  Biometals       Date:  2020-11-25       Impact factor: 2.949

4.  Data needed to respond appropriately to anemia when it is a public health problem.

Authors:  Anne M Williams; O Yaw Addo; Scott D Grosse; Nicholas J Kassebaum; Zane Rankin; Katherine E Ballesteros; Helen Elizabeth Olsen; Andrea J Sharma; Maria Elena Jefferds; Zuguo Mei
Journal:  Ann N Y Acad Sci       Date:  2019-07-02       Impact factor: 6.499

5.  Iron Status and Risk of Stroke.

Authors:  Dipender Gill; Grace Monori; Ioanna Tzoulaki; Abbas Dehghan
Journal:  Stroke       Date:  2018-12       Impact factor: 7.914

6.  Skeletal Lipocalin-2 Is Associated with Iron-Related Oxidative Stress in ob/ob Mice with Sarcopenia.

Authors:  Eun Bee Choi; Jae Hun Jeong; Hye Min Jang; Yu Jeong Ahn; Kyu Hyeon Kim; Hyeong Seok An; Jong Youl Lee; Eun Ae Jeong; Jaewoong Lee; Hyun Joo Shin; Kyung Eun Kim; Gu Seob Roh
Journal:  Antioxidants (Basel)       Date:  2021-05-11

Review 7.  Assessment of iron status in settings of inflammation: challenges and potential approaches.

Authors:  Parminder S Suchdev; Anne M Williams; Zuguo Mei; Rafael Flores-Ayala; Sant-Rayn Pasricha; Lisa M Rogers; Sorrel Ml Namaste
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

Review 8.  Iron Supplementation during Pregnancy and Infancy: Uncertainties and Implications for Research and Policy.

Authors:  Patsy M Brannon; Christine L Taylor
Journal:  Nutrients       Date:  2017-12-06       Impact factor: 5.717

9.  Hematological responses to iron-folate supplementation and its determinants in pregnant women attending antenatal cares in Mekelle City, Ethiopia.

Authors:  Ezra Belay; Asrat Endrias; Birhane Alem; Kedir Endris
Journal:  PLoS One       Date:  2018-10-01       Impact factor: 3.240

10.  Changes in micronutrient and inflammation serum biomarker concentrations after a norovirus human challenge.

Authors:  Anne M Williams; Chandresh N Ladva; Juan S Leon; Ben A Lopman; Vin Tangpricha; Ralph D Whitehead; Andrew E Armitage; Katherine Wray; Alireza Morovat; Sant-Rayn Pasricha; David Thurnham; Sherry A Tanumihardjo; Setti Shahab-Ferdows; Lindsay Allen; Rafael C Flores-Ayala; Parminder S Suchdev
Journal:  Am J Clin Nutr       Date:  2019-12-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.